TELMISARTAN News

← Back to News Overview


TELMISARTAN currently has 0 news articles, with 16 predicted indications.

This page combines the AI-predicted indications for TELMISARTAN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Evidence level: L5
  • Predicted indications (16):
    • cerebrovascular disorder (99.0%)
    • cerebral infarction (99.0%)
    • obsolete susceptibility to ischemic stroke (99.0%)
    • hypertension (99.0%)
    • stroke disorder (99.0%)
    • hypertensive disorder (99.0%)
    • Prinzmetal angina (100.0%)
    • brain stem infarction (100.0%)
    • ABri amyloidosis (100.0%)
    • cerebral artery occlusion (100.0%)
    • pulmonary hypertension owing to lung disease and/or hypoxia (99.9%)
    • pulmonary hypertension with unclear multifactorial mechanism (99.9%)
    • malignant hypertensive renal disease (99.9%)
    • malignant renovascular hypertension (99.9%)
    • intracerebral hemorrhage (99.9%)
    • Braddock syndrome (99.9%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.